Herbas VPB

Print
EN | LT
LT - Farmacinė kompozicija, apimanti nenukleozidinį atvirkštinės transkriptazės inhibitorių
EN - PHARMACEUTICAL COMPOSITION COMPRISING A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR

Legal status

Patent in force

Claims | Licences/Sublicenses
SPA: PA 2019 507
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 401/06 (2006.01)
A61K 31/4439 (2006.01)
A61P 31/18 (2006.01)
European patent
(11) Number of the document 2924034
(13) Kind of document T
(96) European patent application number 15157348.2
Date of filing the European patent application 2011-03-28
(97) Date of publication of the European application 2015-09-30
(45) Date of publication and mention of the grant of the patent 2016-11-02
(46) Date of publication of the claims translation 2016-12-27
Priority applications
(30) Number Date Country code
318824 P 2010-03-30 US
321573 P 2010-04-07 US
Inventors
(72)
Burch, Jason, US
Cote, Bernard, CA
Grantee
(73) Merck Canada Inc., 16711 Trans-Canada Highway, Kirkland QC H9H 3L1, CA
Attorney or representative
(74) Jurga PETNIŪNAITĖ, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) Farmacinė kompozicija, apimanti nenukleozidinį atvirkštinės transkriptazės inhibitorių
  PHARMACEUTICAL COMPOSITION COMPRISING A NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR
Last renewal fee
Payment date Validity (years) Amount
2026-02-09 16 347.00 EUR
Next renewal fee
2027-03-28
Last update date 2026-02-11